Design and characterization of sustained release ketoprofen entrapped carnauba wax microparticles

References

• Poulenc R. (1968). Nouveaux dérivés de l’acide benzoyl-3 phénylacétique et leur préparation. FR 1546478. Nov 22.
   Google Scholar
• Avouac B, Teule M. (1988). Ketoprofen: the European experience. j Clin Pharmacol, 28:S2–S7.
   PubMed Web of Science ®Google Scholar
• Cathcart BJ, Vince JD, Gordon AJ, Bell MA, Chalmers IM. (1973). Studies on 2-(3-benzoylphenyl) propionic acid (Orudis). A double-blind cross-over trial in patients with rheumatoid arthritis and an assessment of its influence on hepatic drug-metabolizing enzymes. Ann Rheum Dis, 32:62–65.
   PubMed Web of Science ®Google Scholar
• Fossgreen J. (1976). Ketoprofen. A survey of current publications. Scand J Rheumatol Suppl, 1976:7–32.
   PubMedGoogle Scholar
• Fossgreen J, Kirchheiner B, Petersen FO, Tophoj E, Zachariae E. (1976). Clinical evaluation of ketoprofen (19.583 R.P.) in rheumatoid arthritis. Double-blind cross-over comparison with indomethacin. Scand J Rheumatol Suppl, 1976:93–98.
   PubMedGoogle Scholar
• Julou L, Guyonnet JC, Ducrot R, Fournel J, Pasquet J. (1976). Ketoprofen (19.583 R.P.) (2-(3-benzoylphenyl)-propionic acid). Main pharmacological properties–outline of toxicological and pharmacokinetic data. Scand J Rheumatol Suppl, 1976:33–44.
   PubMedGoogle Scholar
• Uner M, Gönüllü U, Yener G, Altinkurt T. (2005). A new approach for preparing a controlled release ketoprofen tablets by using beeswax. Farmaco, 60:27–31.
   PubMedGoogle Scholar
• Silva P. (2002). Farmacologia. Rio de Janeiro: Guanabara Koogan.
   Google Scholar
• Jamali F, Brocks DR. (1990). Clinical pharmacokinetics of ketoprofen and its enantiomers. Clin Pharmacokinet, 19:197–217.
   PubMed Web of Science ®Google Scholar
• Liversidge GG. (1981). Ketoprofen. In: Klaus Florey, Rbgabjjefltgh-Gljam, Bruce, CR (eds.) Analytical Profiles of Drug Substances. Academic Press, p. 443–471.
   Google Scholar
• Reynolds JEF. (1996). Martindale, The Extra Pharmacopoeia, London.
   Google Scholar
• Upton RA, Williams RL, Guentert TW, Buskin JN, Riegelman S. (1981). Ketoprofen pharmacokinetics and bioavailability based on an improved sensitive and specific assay. Eur J Clin Pharmacol, 20:127–133.
   PubMed Web of Science ®Google Scholar
• Sancin P, Caputo O, Cavallari C, Passerini N, Rodriguez L, Cini M et al. (1999). Effects of ultrasound-assisted compaction on Ketoprofen/Eudragit S100 mixtures. Eur J Pharm Sci, 7:207–213.
   PubMed Web of Science ®Google Scholar
• Caruso I, Frigerio E, Fumagalli M, Liverta C, Moro L, Tamassia V. (1982). Bioavailability study on a new slow-release formulation of ketoprofen. J Int Med Res, 10:229–233.
   PubMed Web of Science ®Google Scholar
• Houghton GW, Dennis MJ, Rigler ED, Parsons RL. (1984). Comparative pharmacokinetics of ketoprofen derived from single oral doses of ketoprofen capsules or a novel sustained-release pellet formulation. Biopharm Drug Dispos, 5:203–209.
   PubMed Web of Science ®Google Scholar
• Kenawy ER, Abdel-Hay FI, EL-Newehy MH, Wnek GE. (2007). Controlled release of ketoprofen from electrospun poly(vinyl alcohol) nanofibers. Materials Science and Engineering a-Structural Materials Properties Microstructure and Processing, 459:390–396.
   Google Scholar
• Le Liboux A, Teule M, Frydman A, Oosterhuis B, Jonkman JH. (1994). Effect of diet on the single- and multiple-dose pharmacokinetics of sustained-release ketoprofen. Eur J Clin Pharmacol, 47:361–366.
   PubMed Web of Science ®Google Scholar
• Morley KD, Bernstein RM, Hughes GR, Black CM, Rajapakse CN, Wilson L. (1984). A comparative trial of a controlled-release formulation of ketoprofen (‘Oruvail’) and a conventional capsule formulation of ketoprofen (‘Orudis’) in patients with osteoarthritis of the hip. Curr Med Res Opin, 9:28–34.
   PubMed Web of Science ®Google Scholar
• Roda A, Sabatini L, Mirasoli M, Baraldini M, Roda E. (2002). Bioavailability of a new ketoprofen formulation for once-daily oral administration. Int J Pharm, 241:165–172.
   PubMed Web of Science ®Google Scholar
• Brasil. (2008). Resolução RE 2773. Agência Nacional de Vigilância Sanitária-ANVISA.
   Google Scholar
• Lebon C, Marechal D, Suplie P. (2000). Ketoprofen microgranules, method for preparing same and pharmaceutical compositions. WO 0064432 A1. Nov 02.
   Google Scholar
• Kratz CDP, Mayorga PE, Petrovick PR. (2001). Formas farmacêuticas monolíticas como sistemas multiparticulados. Caderno de Farmácia, 17:19–26.
   Google Scholar
• Simpkin GT, Husson I. (1990). Sustained release pharmaceutical formulations. EP 403383 A1. Dez 19.
   Google Scholar
• Pezzini BR, Silva MAS, Ferraz HG. (2007). Formas farmacêuticas sólidas orais de liberação prolongada: sistemas monolíticos e multiparticulados. Revista Brasileira de Ciências Farmacêuticas, 43:491–502.
   Google Scholar
• Debunne A, Vervaet C, Mangelings D, Remon JP. (2004). Compaction of enteric-coated pellets: influence of formulation and process parameters on tablet properties and in vivo evaluation. Eur J Pharm Sci, 22:305–314.
   PubMed Web of Science ®Google Scholar
• Matsumoto A, Kitazawa T, Murata J, Horikiri Y, Yamahara H. (2008). A novel preparation method for PLGA microspheres using non-halogenated solvents. J Control Release, 129:223–227.
   PubMed Web of Science ®Google Scholar
• Miller DA, Mcginity JW, Row III. (2008). Solid Dispersion Technologies. In: Row III, Taft, DR, Mcconville JT (eds.) Advanced Drug Formulation Design to Optimize Therapeutic Outcomes. Informa Healthcare, 451–492.
   Google Scholar
• Sankalia JM, Sankalia MG, Mashru RC. (2008). Drug release and swelling kinetics of directly compressed glipizide sustained-release matrices: establishment of level A IVIVC. J Control Release, 129:49–58.
   PubMed Web of Science ®Google Scholar
• Dukic-Ott A, Thommes M, Remon JP, Kleinebudde P, Vervaet C. (2009). Production of pellets via extrusion-spheronisation without the incorporation of microcrystalline cellulose: a critical review. Eur J Pharm Biopharm, 71:38–46.
   PubMed Web of Science ®Google Scholar
• Ensslin S, Moll KP, Metz H, Otz M, Mäder K. (2009). Modulating pH-independent release from coated pellets: effect of coating composition on solubilization processes and drug release. Eur J Pharm Biopharm, 72:111–118.
   PubMed Web of Science ®Google Scholar
• Iosio T, Voinovich D, Grassi M, Pinto JF, Perissutti B, Zacchigna M et al. (2008). Bi-layered self-emulsifying pellets prepared by co-extrusion and spheronization: influence of formulation variables and preliminary study on the in vivo absorption. Eur J Pharm Biopharm, 69:686–697.
   PubMed Web of Science ®Google Scholar
• Muschert S, Siepmann F, Leclercq B, Carlin B, Siepmann J. (2009). Prediction of drug release from ethylcellulose coated pellets. J Control Release, 135:71–79.
   PubMed Web of Science ®Google Scholar
• Paker-Leggs S, Neau SH. (2009). Pellet characteristics and drug release when the form of propranolol is fixed as moles or mass in formulations for extruded and spheronized Carbopol-containing pellets. Int J Pharm, 369:96–104.
   PubMed Web of Science ®Google Scholar
• Roy P, Shahiwala A. (2009). Multiparticulate formulation approach to pulsatile drug delivery: current perspectives. J Control Release, 134:74–80.
   PubMed Web of Science ®Google Scholar
• Silva I, Gurruchaga M, Goni I. (2009). Physical blends of starch graft copolymers as matrices for colon targeting drug delivery systems. Carbohydrate Polymers, 76:593–601.
   Web of Science ®Google Scholar
• Waters LJ, Pavlakis E. (2007). In vitro controlled drug release from loaded microspheres–dose regulation through formulation. J Pharm Pharm Sci, 10:464–472.
   PubMed Web of Science ®Google Scholar
• Abbaspour MR, Sadeghi F, Afrasiabi Garekani H. (2008). Design and study of ibuprofen disintegrating sustained-release tablets comprising coated pellets. Eur J Pharm Biopharm, 68:747–759.
   PubMed Web of Science ®Google Scholar
• Arica B, Calis S, Atilla P, Durlu NT, Cakar N, Kas HS et al. (2005). In vitro and in vivo studies of ibuprofen-loaded biodegradable alginate beads. J Microencapsul, 22:153–165.
   PubMed Web of Science ®Google Scholar
• Maestrelli F, Zerrouk N, Cirri M, Mennini N, Mura P. (2008). Microspheres for colonic delivery of ketoprofen-hydroxypropyl-β-cyclodextrin complex. Eur J Pharm Sci, 34:1–11.
   PubMed Web of Science ®Google Scholar
• Bechgaard H, Ladefoged K. (1978). Distribution of pellets in the gastrointestinal tract. The influence on transit time exerted by the density or diameter of pellets. J Pharm Pharmacol, 30:690–692.
   PubMed Web of Science ®Google Scholar
• Sjoblom B, Hovas SE. (2004). Method to obtain microparticles. US 6753014 B1. Jun 22.
   Google Scholar
• Cheboyina S, Wyandt CM. (2008a). Wax-based sustained release matrix pellets prepared by a novel freeze pelletization technique I. Formulation and process variables affecting pellet characteristics. Int J Pharm, 359:158–166.
   PubMed Web of Science ®Google Scholar
• Cheboyina S, Wyandt CM. (2008b). Wax-based sustained release matrix pellets prepared by a novel freeze pelletization technique II. In vitro drug release studies and release mechanisms. Int J Pharm, 359:167–173.
   PubMed Web of Science ®Google Scholar
• Windbergs M, Strachan CJ, Kleinebudde P. (2009). Influence of the composition of glycerides on the solid-state behaviour and the dissolution profiles of solid lipid extrudates. Int J Pharm, 381:184–191.
   PubMed Web of Science ®Google Scholar
• Reza MS, Quadir MA, Haider SS. (2003). Comparative evaluation of plastic, hydrophobic and hydrophilic polymers as matrices for controlled-release drug delivery. J Pharm Pharm Sci, 6:282–291.
   PubMed Web of Science ®Google Scholar
• Draper EB, Becker CH. (1966). Some wax formulations of sulfaethylthiadiazole produced by aqueous dispersion for prolonged-release medication. J Pharm Sci, 55:376–380.
   PubMed Web of Science ®Google Scholar
• Kagadis CA, Choulis NH. (1985). Ibuprofen microcapsules from stearic acid. Part 1: Effect of particle size. Pharmazie, 40:807–808.
   PubMed Web of Science ®Google Scholar
• Yamamoto R & Baba M, inventors; Shionogi and Co. Ltd., japanese assignee. Japan Patent Office, Tokyo, Japan. Patent number: JP 1849. 1960 Mar. 08
   Google Scholar
• Adeyeye CM, Price JC. (1991). Development and evaluation of sustained-release ibuprofen-wax microspheres. I. Effect of formulation variables on physical characteristics. Pharm Res, 8:1377–1383.
   PubMed Web of Science ®Google Scholar
• Al-Kassas RS, Gilligan CA, Po ALW. (1993). Processing factors affecting particle-size and in vitro drug-release of sustained-release ibuprofen microspheres. International Journal of Pharmaceutics, 94:59–67.
   Web of Science ®Google Scholar
• Gowda D, Shivakumar H. (2007). Preparation and evaluation of waxes/fat microspheres loaded with lithium carbonate for controlled release. Indian Journal of Pharmaceutical Sciences, 69:251–256.
   Google Scholar
• Hassan EE, Eshra AG, Nada AH. (1995). Formulation of prolonged release lipid micropellets by emulsion congealing-Optimization of ketoprofen entrapment and release. International Journal of Pharmaceutics, 121:149–155.
   Web of Science ®Google Scholar
• Barros-Neto B, Scarminio IS, Bruns RE. (1995). Planejamento e otimização de experimentos, Campinas, UNICAMP.
   Google Scholar
• Jinapong N, Suphantharika M, Jamnong P. (2008). Production of instant soymilk powders by ultrafiltration, spray drying and fluidized bed agglomeration. Journal of Food Engineering, 84:194–205.
   Web of Science ®Google Scholar
• Learoyd TP, Burrows JL, French E, Seville PC. (2008). Chitosan-based spray-dried respirable powders for sustained delivery of terbutaline sulfate. Eur J Pharm Biopharm, 68:224–234.
   PubMed Web of Science ®Google Scholar
• Ouabbas Y, Chamayou A, Galet L, Baron M, Thomas G, Grosseau R, Guilhot B. (2009). Surface modification of silica particles by dry coating: Characterization and powder ageing. Powder Technology, 190:200–209.
   Web of Science ®Google Scholar
• USA. (2007). US Pharmacopoeia. The United States Pharmacopeial Convention.
   Google Scholar
• Costa P, Sousa Lobo JM. (2001). Modeling and comparison of dissolution profiles. Eur J Pharm Sci, 13:123–133.
   PubMed Web of Science ®Google Scholar
• Husson I, Leclerc B, Spenlehauer G, Veillard M, Couarraze G. (1991). Modeling of drug release from pellets coated with an insoluble polymeric membrane. Journal of Controlled Release, 17:163–173.
   Web of Science ®Google Scholar
• Rodrigues PO, Silva MAS. (2005). Avaliação in vitro de medicamentos de liberação prolongada: aplicação de métodos estatísticos, modelos dependentes e independentes de análise. Col Cienc Quím Farm, 34:13–23.
   Google Scholar
• Siepmann J, Peppas NA. (2001). Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv Drug Deliv Rev, 48:139–157.
   PubMed Web of Science ®Google Scholar
• Schwartz JB, Simonell AP, Higuchi WI. (1968). Drug Release from Wax Matrices.I. Analysis of Data with First-Order Kinetics and with Diffusion-Controlled Model. J Pharm Sci, 57:274–277.
   PubMed Web of Science ®Google Scholar
• Higuchi T. (1963). Mechanism of sustained-action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. j Pharm Sci, 52:1145–1149.
   PubMed Web of Science ®Google Scholar
• Korsmeyer RW, Gurny R, Doelker E, Buri P, Peppas NA. (1983). Mechanisms of solute release from porous hydrophilic polymers. International Journal of Pharmaceutics, 15:25–35.
   Web of Science ®Google Scholar
• Peppas NA. (1985). Analysis of Fickian and non-Fickian drug release from polymers. Pharm Acta Helv, 60:110–111.
   PubMedGoogle Scholar
• Vergote GJ, Vervaet C, Van Driessche I, Hoste S, De Smedt S, Demeester J et al. (2001). An oral controlled release matrix pellet formulation containing nanocrystalline ketoprofen. Int J Pharm, 219:81–87.
   PubMed Web of Science ®Google Scholar
• Zhou F, Vervaet C, Remon JP. (1996). Matrix pellets based on the combination of waxes, starches and maltodextrins. International Journal of Pharmaceutics, 133:155–160.
   Web of Science ®Google Scholar
• Sun YM, Chang CC, Huang WF, Liang HC. (1997). Fluidized-bed spray coated porous hydrogel beads for sustained release of diclofenac sodium. Journal of Controlled Release, 47:247–260.
   Web of Science ®Google Scholar